p128
Recombinant proteinexperimental
This is a list of national roads in Latvia: — Wikipedia
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2012 (NCT01746654)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Staphylococcus aureusINHIBITOR
Staphylococcus aureus inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaList of national roads in Latvia ↗
- WikipediaList of National Roads in Latvia ↗
Also known as
- p128
- p128
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01746654 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2012 | GangaGen, Inc., Manipal Acunova Ltd., National University of Singapore |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GangaGen, Inc. | For profit | 1 | 1 | 1 | 2012 |
| Manipal Acunova Ltd. | For profit | 1 | 0 | 1 | 2012 |
| National University of Singapore | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1